Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Long-Term Debt Repayments (2021 - 2023)

GeneDx Holdings (WGS) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $2.0 million as the latest value for Q1 2023.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $2.0 million in Q1 2023 year-over-year; TTM through Jun 2023 was $2.0 million, a 135.85% increase, with the full-year FY2021 number at $3.7 million, down 7.03% from a year prior.
  • Long-Term Debt Repayments was $2.0 million for Q1 2023 at GeneDx Holdings, up from $454000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $2.0 million in Q1 2023 to a low of $394000.0 in Q1 2021.